facebook  linkedin xpix

Diary Dates
Save the date for important iCMLf meetings and programs
calendar

Become a member

Become an iCMLf member - help shape our future
member-button

Please donate

Support our activities
by donating
Donate here

Supporters

We thank all our supporters and partners

supporter-lay2

If you are not a member, please click on "Register". If you have forgotten your password, please click on "Forgot login?" below.

FirstTestiCMLf Diagnosis and Testing Program -
Apply now for 2017 grants

April 2017 - The iCMLf Diagnosis and Testing Program offers seeding grants to hematology institutions in emerging economic regions. The aim of the program is to facilitate the diagnosis, testing and long-term disease monitoring of CML patients in emerging economic regions where it is either limited, or not currently available.

Over five years the iCMLf have awarded 42 grants to enable CML diagnostics to be expanded and enhanced at a local level. This gives both physicians and patients the knowledge to make meaningful decisions on treatment. In 2017 the Foundation will again offer 10 grants with funding of up to $10,000.

Applications will close on the 30th of June 2017. Proposals are welcome to melissa@cml-foundation.org or read more for further information on how to apply.

Read more ...

Jorge Cortes 2013View new presentations on modern CML diagnostics

March 2017 - Two additional presentations have recently been added to the iCMLf Virtual Education Program. These talks cover different aspects on modern diagnostics and were recorded during the ‘Clinical Symposium on Modern Diagnostics’ at the 18th Annual John Goldman Conference on CML in Houston last year. Now view presentations on

View other presentations on modern diagnostics here.

Rare Disease Day 2017Logo Rare Disease Day

February 2017 - February 28th is Rare Disease Day! Today organizations supporting rare diseases and patients all over the world raise awareness for rare diseases aiming to improve access to treatment and care for 300 millions of people affected by rare diseases.

The outcomes for patients with CML have improved significantly over the past years thanks to new treatment options available, but there is still a lot to do to grant equal access to appropriate treatment and monitoring for patients around the world, especially in emerging economic regions– one of the core objectives of the iCMLf.

Learn more about rare disease here, courtesy of the Mesothelioma Cancer Alliance.

Make sure to get involved using #RareDiseaseDay

2017 iCMLf Prizes awarded -GoldmanPrize medal RGB reduc 
Congratulations to the recipients

February 2017 - Each year the International CML Foundation awards three prizes to recognise and reward outstanding achievements and contributions to the management and understanding of CML.

We are delighted to share the well-deserved 2017 prize recipients:

  • Rowley Prize - Professor Tessa Holyoake. This award acknowledges outstanding contributions to the understanding of the biology of CML and is awarded to Tessa Holyoake in recognition of her ground breaking work understanding and targeting CML stem cells.
  • Goldman Prize – Professor Tim Hughes. This prize recognises outstanding contributions to clinical management of CML and is awarded to Tim Hughes in recognition of his wide-ranging contributions to clinical research and CML treatment.
  • iCMLf Prize – Professor Jerry Radich. The iCMLf prize recognises outstanding contributions to improving the treatment of CML in the emerging economic regions. Jerry Radich is awarded the 2017 iCMLf prize for his dedication to developing methods to increase access to molecular monitoring in these regions.

Read more ...

iCMLf Forum 2016:
View webstreams on 'Managing the high risk CML patient'iCMLf Forum 2016 Podium

February 2017 - Webstreams of the presentations from the iCMLf Forum for Physicians from Emerging Regions 2016 are now available to view. This year's Forum focused on 'Managing the high risk CML patient'. Presenters give the local emerging regions perspectives on each topic followed iCMLf experts and a discussion with the audience.

Topics include:

  1. Meeting the new challenges in CML therapy 
    Professor Brian Druker (USA) 
  2. Frontline therapy challenges 
    Professor Tapan Saikia (India) and Professor Andreas Hochhaus (Germany)
  3. Comorbidities when managing CML
    Dr Anthony Oyekunle (Botswana) and Dr Delphine Réa (France)

Read more ...

CML highlights from ASH 2016 - read an overviewLogo ASH 3

January 2016 - Important CML news was presented at the 58th Meeting of the American Society of Hematology (ASH) in San Diego. This included; data to help guide treatment discontinuation and TFR monitoring, Phase I results of a new tyrosine kinase inhibitor and new findings on the use of generics. We have compiled a selection of these CML highlights to assist you follow the latest scientific advancements in CML.

Read more ...